Trials / Terminated
TerminatedNCT02145676
OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a safety and efficacy study of onabotulinumtoxinA in poststroke patients with upper limb spasticity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | onabotulinumtoxinA | OnabotulinumtoxinA injected into predefined muscles of the study limb on Day 1. |
| DRUG | placebo (normal saline) | Placebo (normal saline) injected into predefined muscles of the study limb on Day 1. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-05-23
- Last updated
- 2017-04-12
- Results posted
- 2017-02-14
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02145676. Inclusion in this directory is not an endorsement.